Priorities in polycystic ovary syndrome

---

• 1.
• Lobo RA, Carmina E. The importance of diagnosing the polycysticovary syndrome. Ann Intern Med 2000; 132: 989-993.
• 2.
• Nestler JE. Polycystic ovary syndrome: a disorder for thegeneralist. Fertil Steril 1998; 70: 811-812.
• 3.
• Franks S. Morphology of the polycystic ovary in polycystic ovarysyndrome. In: Dunaif A, Given JR, Haseltine FP, Merriam GR, editors.Polycystic ovary syndrome. Boston: Blackwell; 1992: 19-28.
• 4.
• Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably themost common endocrinopathy is associated with significantmorbidity in women. J Clin Endocrinol Metab 1999; 84:1897-1899.
• 5.
• Gammon MD, Thompson WD. Polycystic ovaries and the risk of breastcancer. Am J Epidemiol 1991; 134: 818-824.
• 6.
• Legro RS, Kunselman AR, Dodson WC, et al. Prevalence and predictorsof risk for type 2 diabetes mellitus and impaired glucose tolerance inpolycystic ovary syndrome: a prospective, controlled study in 254affected women. J Clin Endocrinol Metab 1999; 84: 165-169.
• 7.
• Wild S, Pierpoint T, McKeigue P, et al. Cardiovascular disease inwomen with polycystic ovary syndrome at long-term follow-up: aretrospective cohort study. Clin Endocrinol (Oxf) 2000; 52:595-600.
• 8.
• Ehrmann DA, Sturis J, Byrne MM, Karrison T, et al. Insulin secretorydefects in polycystic ovary syndrome. Relationship to insulinsensitivity and family history of non-insulin-dependent diabetesmellitus. J Clin Invest 1995; 96: 520-527.
• 9.
• Murray RD, Davison RM, Russell RC, et al. Clinical presentation ofPCOS following development of an insulinoma: case report. HumReprod 2000; 15: 86-88.
• 10.
• Norman RJ, Kidson WJ, Cuneo RC, Zacharin MR. Metformin andintervention in polycystic ovary syndrome. Med J Aust 2001;174: 580-583.
• 11.
• Norman R, Clark A. Obesity and reproductive disorders. ReprodFertil Develop 1998; 10: 55-63.
• 12.
• Glueck CJ, Phillips H, Cameron D, et al. Continuing metforminthroughout pregnancy in women with polycystic ovary syndromeappears to safely reduce first-trimester spontaneous abortion: apilot study. Fertil Steril 2001; 75: 46-52.
• 13.
• Pasquali R, Gambineri A, Biscotti D, et al. Effect of long-termtreatment with metformin added to hypocaloric diet on bodycomposition, fat distribution, and androgen and insulin levels inabdominally obese women with and without the polycystic ovarysyndrome. J Clin Endocrinol Metab 2000; 85: 2767-2774.
• 14.
• Nestler JE, Jakubowicz DJ, Reamer P, et al. Ovulatory andmetabolic effects of D-chiro-inositol in the polycysticovary syndrome. N Engl J Med 1999; 340: 1314-1320.
• 15.
• Chang PL, Lindheim SR, Lowre C, et al. Normal ovulatory women withpolycystic ovaries have hyperandrogenic pituitary-ovarianresponses to gonadotropin-releasing hormone-agonist testing.J Clin Endocrinol Metab 2000; 85: 995-1000.